Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.South Dakota-based technology and pharmaceutical company PharmaCline has licensed the rights for Phillips drug delivery technology and its existing antibiotic products.
Subscribe to our email newsletter
Active pharmaceutical ingredients are delivered through pathogen cell walls using Phillips’ drug delivery technology.
When the active pharmaceutical ingredients are combined with tetracycline, the resulting product is a broad spectrum over-the-counter (OTC) antibiotic, which can be administered topically.
The tests for the new antibiotic drug demonstrated that it is effective against topical gram-negative and gram-positive bacteria.
PharmaCline is seeking Series C funding partners to support upcoming US and international OTC product launches.